Search clinical trials for: ER/PR/HER2 negative
Total 15804 results
-
OncoSec Medical IncorporatedCompletedER-Negative PR-Negative HER2-Negative Breast CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI); Syndax PharmaceuticalsTerminatedBreast Cancer | Invasive Breast Cancer | ER-Negative PR-Negative HER2-Negative Breast CancerUnited States
-
Peregrine PharmaceuticalsWithdrawnBreast Cancer | Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | Triple-Negative Breast Cancer | Triple-Negative Breast Neoplasm | ER-Negative PR-Negative HER2-Negative Breast Neoplasms | ER-Negative PR-Negative HER2-Negative Breast Cancer
-
University of Wisconsin, MadisonNational Cancer Institute (NCI)Recruiting
-
Nippon Kayaku Co., Ltd.CompletedTriple Negative Breast CancerUnited States
-
Istituto Oncologico Veneto IRCCSUniversity of Padova; Dipartimento di scienze chirurgiche, Oncologiche e GastroenterologicheActive, not recruitingTriple Negative Breast NeoplasmsItaly, United Kingdom
-
Masonic Cancer Center, University of MinnesotaActive, not recruitingTriple Negative Breast Cancer | HER2-positive Breast Cancer | TN ER-/PR-/HER2- Breast Cancer | ERany/PRany/HER2+ Breast CancerUnited States
-
Leo W. Jenkins Cancer CenterTerminatedBreast CancerUnited States
-
HiberCell, Inc.Merck Sharp & Dohme LLCCompletedMalignant Neoplasm of BreastUnited States
-
Memorial Sloan Kettering Cancer CenterContext Therapeutics Inc.WithdrawnMetastatic Breast Cancer | Unresectable Breast CancerUnited States
-
Ruth O'ReganUniversity of Rochester; Puma Biotechnology, Inc.RecruitingBreast Cancer | HER2-positive Breast Cancer | ER Positive Breast Cancer | PR-Positive Breast CancerUnited States
-
Jennifer Lee Caswell-JinNational Cancer Institute (NCI); QED Therapeutics, Inc.TerminatedBreast Cancer | HER2-negative Breast Cancer | ER Positive Breast Cancer | PR-Positive Breast CancerUnited States
-
PfizerCompletedER/PR(+), Her2(-) Breast CancerTaiwan
-
Jules Bordet InstituteHoffmann-La Roche; Breast International Group; Institut Curie; International Drug...SuspendedHER2-positive Breast Cancer | ER-Negative Breast Cancer | PR-Negative Breast Cancer | Node-negative Breast CancerKorea, Republic of, France, Israel, Belgium, Switzerland, Australia
-
Massachusetts General HospitalDana-Farber Cancer Institute; Beth Israel Deaconess Medical Center; Genentech... and other collaboratorsCompletedBreast CancerUnited States
-
Legacy Health SystemTerminatedMetastatic Breast CancerUnited States
-
Yale UniversityNovartis PharmaceuticalsTerminatedBreast CancerUnited States
-
Massachusetts General HospitalGilead SciencesRecruitingTriple Negative Breast Cancer | Invasive Breast Cancer | HER2-negative Breast Cancer | ER-Negative Breast Cancer | PR-Negative Breast CancerUnited States
-
Massachusetts General HospitalPuma Biotechnology, Inc.; Celcuity, Inc.WithdrawnMetastatic Breast Cancer | Invasive Breast Cancer | HER2-negative Breast Cancer | ER Positive Breast Cancer | PR-Positive Breast Cancer | Stage IV (Metastatic) Breast CancerUnited States
-
Milton S. Hershey Medical CenterNovartisTerminated
-
Fuda Cancer Hospital, GuangzhouJinan University GuangzhouCompleted
-
MedSIRTerminated
-
AstraZenecaRecruitingTriple Negative Breast NeoplasmsUnited States, Korea, Republic of, Canada, Taiwan, United Kingdom, Poland
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruiting
-
H. Lee Moffitt Cancer Center and Research InstituteNovartisCompletedBreast Cancer | Breast Cancer - Female | Breast Cancer - MaleUnited States
-
Dana-Farber Cancer InstituteGenentech, Inc.; ExelixisCompletedBreast Cancer | Brain Tumor - MetastaticUnited States
-
VelosBio Inc.CompletedGastric Cancer | Pancreatic Cancer | NSCLC | Platinum-resistant Ovarian Cancer | Triple-negative Breast Cancer | ER-positive Breast Cancer | HER2-negative Breast Cancer | Non-squamous Non-small-cell Lung Cancer | Estrogen-receptor-positive Breast Cancer | Progesterone-receptor-positive Breast Cancer | Estrogen-receptor-negative... and other conditionsUnited States, Canada
-
Ian E. Krop, MD, PhDMassachusetts General Hospital; Genentech, Inc.; Brigham and Women's Hospital; New...Completed
-
Hoosier Cancer Research NetworkClovis Oncology, Inc.CompletedBreast CancerUnited States
-
AstraZenecaCompletedAdvanced Solid Malignancies | Breast Cancer - ER+, HER2 - | Breast Cancer - ER+, HER2-, PIK3CA Gene MutationUnited States, United Kingdom
-
Hutchison Medipharma LimitedBeiGeneActive, not recruitingColorectal Cancer | Triple Negative Breast Cancer | Endometrial Cancer | Solid Tumor, Unspecified, AdultUnited States
-
Hoffman OncologyDSCS CROActive, not recruiting
-
University of ArkansasCompletedBreast Neoplasms | Triple Negative Breast CancerUnited States
-
Rush University Medical CenterTerminatedMetastatic Breast CancerUnited States
-
QuantumLeap Healthcare CollaborativeRecruitingSolid Tumor | Metastatic Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | Solid Tumor, Adult | Solid Carcinoma | HER2-positive Metastatic Breast Cancer | Progesterone Receptor-positive Breast Cancer | HER2-negative Breast Cancer | Estrogen Receptor Positive... and other conditionsUnited States
-
University of Tennessee Cancer InstituteGenentech, Inc.; Celgene Corporation; National Comprehensive Cancer NetworkUnknownBreast CancerUnited States
-
Hellenic Society of Medical OncologyRecruitingMetastatic Breast CancerGreece
-
SCRI Development Innovations, LLCNovartisCompleted
-
Synta Pharmaceuticals Corp.CompletedBreast Cancer | Triple Negative Breast Cancer | HER-2 Positive Breast Cancer | ER/Progressive Response (PR) + Refractory to Prior Hormonal TreatmentSpain, United States, Argentina, Belgium, Brazil, Korea, Republic of, Peru, United Kingdom
-
Nippon Kayaku Co., Ltd.CompletedAdvanced Solid Tumors | Metastatic Triple Negative Breast CancerUnited States
-
SanofiNo longer available
-
AstraZenecaRecruitingER-Positive HER2-Negative Breast CancerUnited States, Israel, Spain, Korea, Republic of, Italy, Poland, Belgium, Norway, Bulgaria, France, Germany, United Kingdom, Japan, Taiwan, Canada, Hungary, Australia, Austria, Portugal, Turkey, Russian Federation, Slovakia, Switzer...
-
Tianjin Hemay Oncology Pharmaceutical Co., LtdRecruiting
-
UNICANCERMinistry of Health, FranceActive, not recruitingPrimary Non-metastatic Breast Cancer | Who Remain Disease-freeFrance
-
Hospital do CoracaoPfizerRecruitingMetastatic Breast Cancer | Breast Cancer Stage IVBrazil
-
University of VirginiaWithdrawnBreast Cancer | Estrogen Receptor-positive Breast CancerUnited States
-
AstraZenecaActive, not recruitingER+ HER2- Advanced Breast CancerUnited States, Spain, United Kingdom
-
Jiangsu HengRui Medicine Co., Ltd.Terminated
-
Dartmouth-Hitchcock Medical CenterRecruitingAdvanced Breast CancerUnited States
-
Clovis Oncology, Inc.TerminatedBreast Cancer | Metastatic Breast Cancer | Estrogen Receptor Positive | Triple Negative | HER2 | HER2 Positive | MBC | ERUnited States